BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1444225)

  • 1. Cytotoxic action of cyclosporins on human tumor cell lines is not dependent on immunosuppressive activity.
    Larssson R; Fridborg H; Csoka K; Bergh J; Nygren P
    Anticancer Res; 1992; 12(5):1581-5. PubMed ID: 1444225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin.
    Larsson R; Bergh J; Nygren P
    Anticancer Res; 1991; 11(1):455-9. PubMed ID: 1850223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells.
    Chen G; Teicher BA; Frei E
    Anticancer Res; 1996; 16(6B):3499-505. PubMed ID: 9042212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytotoxic effect and the multidrug resistance reversing action of lignans from Phyllanthus amarus.
    Leite DF; Kassuya CA; Mazzuco TL; Silvestre A; de Melo LV; Rehder VL; Rumjanek VM; Calixto JB
    Planta Med; 2006 Dec; 72(15):1353-8. PubMed ID: 17054045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
    Larsson R; Nygren P
    Int J Cancer; 1990 Jul; 46(1):67-72. PubMed ID: 2194983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
    Choi CH; Kang G; Min YD
    Planta Med; 2003 Mar; 69(3):235-40. PubMed ID: 12677527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A; Drobná Z; Barancík M
    Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.
    Chambers SK; Hait WN; Kacinski BM; Keyes SR; Handschumacher RE
    Cancer Res; 1989 Nov; 49(22):6275-9. PubMed ID: 2804973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
    Bull Cancer; 1994 Feb; 81(2):93-103. PubMed ID: 7894124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible role for cyclosporins in cancer chemotherapy.
    Twentyman PR
    Anticancer Res; 1988; 8(5A):985-93. PubMed ID: 3052264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
    Jonsson B; Nilsson K; Nygren P; Larsson R
    Anticancer Drugs; 1992 Dec; 3(6):641-6. PubMed ID: 1363199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of cyclosporin A and a non-immunosuppressive cyclosporin against multidrug resistant leukemic cell lines.
    Hait WN; Stein JM; Koletsky AJ; Harding MW; Handschumacher RE
    Cancer Commun; 1989; 1(1):35-43. PubMed ID: 2640154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
    Nygren P; Larsson R
    Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
    Ishida Y; Shimada Y; Shimoyama M
    Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.